Genetically recombinant antibody composition having enhanced effector activity

Details for Australian Patent Application No. 2008208288 (hide)

Owner Kyowa Hakko Kirin Co., Ltd.

Inventors Niwa, Rinpei; Shitara, Kenya; Natsume, Akito

Agent Spruson & Ferguson

Pub. Number AU-A-2008208288

PCT Pub. Number WO2008/090959

Priority 2007-013640 24.01.07 JP

Filing date 24 January 2008

Wipo publication date 31 July 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/090959 Priority application(s): WO2008/090959

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008208313-Mask and member for mount on mask

2008208224-Heterocyclidene-N-(aryl)acetamide derivative